FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to rheumatology. Method of rheumatoid arthritis treatment includes therapy by non-steroid anti-inflammatory medications, glucocorticosteroids and cytostatics, and patient is additionally prescribed selenase 1 time per day in form of intravenous drop infusions in dose 2 ml (100 mcg), diluted in 200 ml of physiologicalsolution, during 10 days, with following transfer to per oral application of selenase in dose 2 ml (100 mcg of selenium) 1 time per day, course lasting to 6 months.
EFFECT: invention ensures increase of rheumatoid arthritis treatment efficiency and correction of autoimmune processes in case of said disease, makes it possible to reduce clinical symptoms of rheumatoid arthritis, reduce treatment terms, improve immunity properties and life quality of said category of patients.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING RHEUMATIC ARTHRITIS | 1992 |
|
RU2038082C1 |
METHOD OF TREATING DISSEMINATED LICHEN ACUMINATUS ASSOCIATED WITH CHRONIC GRANULOMATOUS PERIODONTITIS | 2019 |
|
RU2703313C1 |
RHEUMATOID ARTHRITIS TREATMENT METHOD | 1999 |
|
RU2144397C1 |
METHOD FOR PRODUCTION OF POLYCLONAL T-CELL VACCINE USEFUL IN TREATMENT OF IMMUNOLOGICAL DISORDERS | 2004 |
|
RU2277422C2 |
METHOD FOR TREATMENT OF PSEUDORHEUMATISM | 2007 |
|
RU2339385C1 |
METHOD FOR TREATMENT OF HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS | 2015 |
|
RU2580301C1 |
THERAPY OF PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS WITH APPLYING COMBINATION OF TUMOUR NECROSIS ALPHA FACTOR ANTIBODIES | 2007 |
|
RU2360717C1 |
METHOD OF TREATING CHRONIC TONSILLITIS | 2013 |
|
RU2530632C1 |
METHOD FOR PREVENTING OSSEOUS-CARTILAGINOUS DESTRUCTION IN CASE OF RHEUMATOID ARTHRITIS | 2003 |
|
RU2268719C2 |
METHOD OF TREATING PATIENTS WITH RHEUMATOID ARTHRITIS | 2014 |
|
RU2573998C1 |
Authors
Dates
2011-12-27—Published
2010-04-12—Filed